Muco Rhinathiol Adultes, Sans Sucre (Carbocisteine)

Carbocisteine is employed as a mucolytic to improve clearance of airway secretions in chronic respiratory disorders such as COPD, bronchitis and productive cough.

• Chronic obstructive pulmonary disease (COPD): thins mucus, facilitating expectoration, reducing cough frequency and improving airflow in patients with chronic bronchial obstruction.
• Bronchitis: decreases sputum viscosity, aiding cough effectiveness and providing symptomatic relief in acute or chronic bronchial inflammation.
• Cough with thick mucus: loosens tenacious secretions, promoting easier clearance and alleviating airway obstruction during productive cough episodes.

• Carbocisteine acts by cleaving disulfide bonds within mucoproteins, which lowers the molecular weight and viscosity of mucus. This chemical modification disrupts the gel structure of sputum, making it less sticky and easier for ciliary action and cough reflex to transport the secretions out of the airways. The result is enhanced mucociliary clearance without significant bronchoconstriction. The effect is dose‑dependent and contributes to symptomatic relief in patients with excessive or tenacious sputum.

Carbocisteine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild stomach upset reported in some patients.
• Diarrhea: loose stools occurring during treatment.
• Dyspepsia: indigestion or upper abdominal discomfort.
• Headache: transient mild headache.
• Skin rash: mild erythema or itching.
• Dizziness: light‑headed sensation.
• Bronchial irritation: temporary worsening of cough.

Serious or Rare Side Effects

• Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention.
• Hepatic dysfunction: elevated liver enzymes indicating possible liver involvement.
• Severe gastrointestinal bleeding: rare but serious bleeding in the digestive tract.
• Hematologic abnormalities: unexplained bruising or low blood cell counts.
• Acute bronchospasm: paradoxical tightening of airway muscles, though uncommon.

When using carbocisteine, certain precautions should be observed to ensure safe and effective therapy.

• Renal impairment: dose may need adjustment in patients with reduced kidney function.
• Hepatic disease: monitor liver function tests during prolonged use.
• Concomitant mucolytics: avoid simultaneous use with other mucolytic agents unless advised.
• Pregnancy: safety not established; use only if potential benefit outweighs risk.
• Elderly: start with lowest effective dose and monitor for adverse effects.
• Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Carbocisteine can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid)

• Antitussives containing codeine: may counteract mucolytic effect by suppressing cough reflex.
• Highly protein‑bound drugs: carbocisteine may displace them, increasing free drug levels (e.g., warfarin).

Moderate Interactions (Monitor Closely)

• Antibiotics (e.g., macrolides): may increase risk of gastrointestinal upset.
• Bronchodilators: monitor for additive effects on airway tone.
• Antihistamines: watch for enhanced sedation or dizziness.
• NSAIDs: potential for increased gastrointestinal irritation.